Clinical Trial Update: Effects of Intranasal Fluticasone Plus Azelastine on Airway Inflammation in Patients With Asthma & Allergic Rhinitis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating intranasal fluticasone plus azelastine for airway inflammation in patients with asthma and allergic rhinitis; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma

Drugs mentioned

• AZELASTINE (Azelastine)
• intranasal fluticasone (fluticasone)

Snippet

Sponsor: University of Dundee | Conditions: Asthma, Allergic, Rhinitis,Allergic | Phase 4 | Status: TERMINATED